DCP.JSE Dis-Chem Pharmacies
- Market cap
- ZAC 23.9B
- P/E
- 2,451.8x
- P/B
- 423.90x
- ROE
- 17.3%
- Dividend yield
- 1.14%
- Fundamental score
- 2.1/5
Ratios use the latest price and the fiscal year ending Feb 2026.
Is DCP.JSE undervalued?
Graham numberThe Graham number of Dis-Chem Pharmacies cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Dis-Chem Pharmacies fundamental analysis
11 of 22 checks passedROE 1/2
Moderate return on equity (17.3%), between 10% and 20%.
ROA 0/1
Return on assets (4.7%) is below the industry median (4.7%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-17.0%) is not above the 5-year average (8.0% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-17.0%) is below the industry median (-17.0%).
Revenue Growth 1/2
Revenue grew 9.4% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
High debt to equity (117.6%), above 100%.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 0/1
EBIT is 2.9x against interest expense, below 5x.
PE vs Market 0/1
PE (24.5x) is above the market median (9.1x).
PE vs Industry 0/1
PE (24.5x) is above the industry median (17.8x).
PBV 0/1
Price to book (4.2x) is above the industry median (3.3x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 103.9, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 3.08, above 1.
Dividend Yield 0/2
Dividend yield (2.2%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 1/2
Dividends paid without a cut of more than 10% for 6 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 1/1
Payout ratio is 53.6%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Dis-Chem Pharmacies stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Dis-Chem Pharmacies
Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments: Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensaries, personal care and beauty, healthcare and nutrition, baby care, and other products. The company also provides pharmaceutical, health, and front shop products …
Full company profileDis-Chem Pharmacies financial statements
Dis-Chem Pharmacies annual financial statements (ZAR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 17.3B | 19.6B | 21.4B | 24.0B | 26.3B | 30.4B | 32.7B | 36.3B | 39.2B | 42.8B |
| Gross Profit | 4.21B | 4.77B | 5.22B | 5.56B | 5.84B | 6.83B | 7.59B | 8.22B | 8.80B | 8.15B |
| Operating Income | 1.13B | 1.13B | 1.22B | 1.25B | 1.27B | 1.54B | 1.74B | 1.78B | 2.10B | 1.99B |
| EBITDA | 1.31B | 1.33B | 1.89B | 1.85B | 1.99B | 2.39B | 2.75B | 2.91B | 3.30B | 3.25B |
| Net Income | 612M | 684M | 735M | 598M | 669M | 853M | 1.00B | 984M | 1.18B | 979M |
| EPS | 0.75 | 0.80 | 0.85 | 0.70 | 0.78 | 0.99 | 1.16 | 1.15 | 1.37 | 1.14 |
| Balance Sheet | ||||||||||
| Total Assets | 5.90B | 7.13B | 8.84B | 10.6B | 13.2B | 14.1B | 15.5B | 17.5B | 19.3B | 20.7B |
| Total Liabilities | 4.77B | 5.44B | 6.73B | 8.27B | 10.2B | 10.7B | 11.6B | 13.0B | 14.0B | 15.0B |
| Shareholders' Equity | 1.11B | 1.63B | 2.04B | 2.25B | 2.91B | 3.32B | 3.90B | 4.47B | 5.22B | 5.64B |
| Cash & Short-term Investments | 295M | 280M | 177M | 452M | 540M | 706M | 287M | 884M | 585M | 500M |
| Total Debt | 1.79B | 1.87B | 2.09B | 3.70B | 4.48B | 4.51B | 4.97B | 5.69B | 6.24B | 6.64B |
| Cash Flow | ||||||||||
| Operating Cash Flow | 159M | 45.0M | 336M | 1.26B | 1.12B | 1.38B | 854M | 1.89B | 905M | 2.32B |
| Capital Expenditure | 221M | 253M | 395M | 363M | 401M | 377M | 1.09B | 1.03B | 1.40B | 1.10B |
| Free Cash Flow | -62.3M | -208M | -58.5M | 894M | 723M | 1.00B | -236M | 863M | -497M | 1.21B |
| Ratios | ||||||||||
| ROE | 55.3% | 41.9% | 36.1% | 26.5% | 23.0% | 25.7% | 25.6% | 22.0% | 22.6% | 17.3% |
| ROA | 10.4% | 9.6% | 8.3% | 5.7% | 5.1% | 6.1% | 6.4% | 5.6% | 6.1% | 4.7% |
| Net Profit Margin | 3.5% | 3.5% | 3.4% | 2.5% | 2.5% | 2.8% | 3.1% | 2.7% | 3.0% | 2.3% |
| Debt to Equity | 1.62x | 1.15x | 1.02x | 1.64x | 1.54x | 1.36x | 1.28x | 1.27x | 1.19x | 1.18x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Dis-Chem Pharmacies dividends
- Dividend yield
- 1.14%
- Forward dividend
- 0.32 ZAC
- Payout ratio
- 53.6%
- Ex-dividend date
- Jun 17, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | ZAR 524M | 0.61 | 53.6% |
| 2025 | ZAR 472M | 0.55 | 40.0% |
| 2024 | ZAR 424M | 0.49 | 43.1% |
| 2023 | ZAR 466M | 0.54 | 46.6% |
| 2022 | ZAR 459M | 0.53 | 53.7% |
| 2021 | ZAR 39.5M | 0.05 | 5.9% |
| 2020 | ZAR 266M | 0.31 | 44.5% |
| 2019 | ZAR 302M | 0.35 | 41.1% |
| 2018 | ZAR 233M | 0.27 | 34.0% |
| 2017 | ZAR 910M | 1.11 | 148.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Dis-Chem Pharmacies
- Insiders 35.43%
- Institutions 64.57%
- Public & others 0.00%
- Shares outstanding 856M
- Free float 563M
Dis-Chem Pharmacies company profile
- Company name
- Dis-Chem Pharmacies
- Ticker
- DCP.JSE
- ISIN
- ZAE000227831
- Exchange
- Johannesburg Exchange
- Sector
- Healthcare
- Industry
- Consumer Staples Distribution & Retail
- Fiscal year end
- February
- Address
- 23 Stag Road, Midrand, South Africa, 1682
- Phone
- 27 10 589 2200
- Website
- dischemgroup.com
About Dis-Chem Pharmacies
Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments: Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensaries, personal care and beauty, healthcare and nutrition, baby care, and other products. The company also provides pharmaceutical, health, and front shop products in the wholesale market, health insurance products, occupational health clinics, and a psychological wellbeing platform. In addition, it offers customer loyalty programs. The company was founded in 1978 and is headquartered in Midrand, South Africa.
Dis-Chem Pharmacies management
6- Mr. Rui Manuel Morais C.A.CEO & Executive Director · born 1984
- Ms. Julia Denise PopeCFO & Executive Director
- Christopher J. WilliamsPrescribed Officer
- Ms. Nikki J. LumleyCompany Secretary
- C. A. SwanepoelPrescribed Officer
- T. J. PonterPrescribed Officer